Part I General Provisions
1. The name of this organization is the ISPOR Chinese
Medical Doctor Association Pharmacoeconomics Chapter
(ISPOR Chinese MDA-PE Chapter) as well as the Pharmacoeconomic
Expert Working Group of the Chinese Medical Doctor
Association. (Herein referred to as - Organization).
2. The Chinese Medical Doctor Association is a voluntary,
legal organization complying with all the laws and
regulations in China.
3. The Organization maintains affiliation as a component
chapter of the International Society for Pharmacoeconomics
and Outcomes Research (ISPOR).
4. The Organization operates on the territory of
mainland China.
5. The office of the Organization is at the address:
Room 1802, A Tower Junfenghuating No.69 Beichen West
Road, Chaoyang District, Beijing P.R. China.
Part II Mission and Objective
1. The mission of the Organization is to:
- Increase
recognition of pharmacoeconomics and outcomes research
in domestic medical doctors, physicians, pharmaceutists
and other professionals in health care and related
branches through professional trainings.
- Provide an environment where domestic
medical doctors, physicians, pharmaceutists, decision-makers
and other professionals in health care and related
branches can share knowledge and information all
through China.
- Serve as a bridge in bringing together
domestic medical doctors, pharmaceutists and other
professionals in health care and related branches
and members of the pharmaceutical industry, health-related
organizations, and academia.
- Act as a resource of pharmacoeconomics
and outcomes research in China for individuals interested
in pharmacoeconomics and outcomes research.
2. The objective of the Organization is to:
- Utilize the scarce health care resource in
China to a maximum to improve the health status of
the Chinese population.
- Compile and update China pharmacoeconomic
guideline and make it the national industry standard
for pharmacoeconomic evaluation to promote the development
of pharmacoeconomics in China.
- Foster research programs to study how pharmacoeconomic
evaluation can play a bigger role in China’s
health policy.
- Spread the idea of pharmacoeconomics
to direct reasonable drug purchasing in China.
- Create a communication platform for an
exchange of information and development of all forms
of collaboration between its members and organizations.
- Foster the transfer pharmacoeconomic
results into practice and suggest measures in public
health policies.
- Promote introduction of newest medical achievements
and pharmacoeconomics & outcomes news.
- Organize various meetings with foreign
experts to discuss and popularize pharmacoeconomics
in China.
- Foster the economic evaluation into drug
evaluation to promote scientific drug pricing and
rational drug usage in China.
- Serve as information resource for academic
researches.
- Communicate pharmacoeconomic information
via electronic and printed mass media and information
networks.
- Organize lectures and seminars on urgent
questions of development of public healthcare services.
- Establish and support communications
with non-governmental foreign and international organizations
for realization of the purposes determined by the
present Charter.
Part III Membership
1. Membership in the Organization and exit from it
is voluntary. If he/she agrees with the mission and
objectives of the Organization, he/she can lodge a
written application to the management board for approval.
The application contains basic information of the applicant
and a document about reimbursement of the annual fee.
The membership is renewed annually by reimbursement
of the annual fee in the following year.
2. The members of this Organization include:
- Individual members: Anybody who have
achieved 18-year's age, of China, and foreign citizens
can make an application to join this organization.
If the application is allowed and membership fee
is paid, they can become individual members of the
organization to share the mission and objectives.
- Organizational members: Legal organizations
which have interests in pharmacoeconomics and outcome
research in China can make an application to join
this organization. If the application is allowed
and membership due is paid, they can become organizational
members of the organization to share the mission
and objectives.
- Sponsoring members: Organizations or
individuals that give financial supports to this
organization and agree on the mission of the organization,
with the permission of the management board, can
become sponsoring members. The sponsoring membership
is not subject to payment of membership fees.
- Honorary members: Honorary members of
the organization include experts in the expert group
and natural person who has merited of the development
of the pharmacoeconomics, healthcare, medical science
or development of the organization in a particularly
important manner. The honorary membership is not
subject to payment of membership fees.
- At least three members of the Organization’s
management are ISPOR members.
3. The members of the Organization have the equal
rights to:
- Take personal part in activities of the
Organization.
- Get relative information service from
the Organization.
- Take personal part in lectures and trainings
the Organization initiates.
- Communicate with experts in pharmacoeconomics
field at home and abroad.
- Bring in the offers to all bodies of
the Organization on their activity.
- Use
material base and international communications of
the Organization.
4. The members of the Organization
bear equal duties to:
- Carry out the requirements of the Organization.
- Participate in work on realization of
the purposes and tasks of the Organization.
- Not suppose actions discrediting the
Organization.
- Pay membership fees in a due and timely
manner.
5. The membership automatically ceases:
- By non-reimbursement of the membership
fee within the term.
- By not participating in any activities
the organization holds in two consecutive years.
- By withdrawal from the Organization on
the basis of a written statement delivered to the
management board, which is effective on the day of
delivery.
- By seriously infringed the Constitution
of the Organization
- By acting against mission and objective
of the Organization
- By damaging the good reputation of the
Organization
- By violation of the law of Peoples’ Republic
of China
- By death or declaration of death
Part IV Organization Management
1. The Organization’s management includes:
- Membership
- Executive Board
2. Membership is the supreme body of the organization
and has the following rights:
- Approve the constitution and any amendments
by 2/3 vote.
- Elect and revoke any Officer of the Executive
Board.
- Examine the annual report of activities
and financial transaction s of the Organization.
- Members may audit certain expert meetings
with permission of the Organization.
- The Organization holds at least one membership
conference every year and decisions shall be made
by a majority of the members present. Acceptance
of a decision and a change in the constitution require
an affirmative vote of 2/3 members present at the
membership conference.
3. Executive Board is the executive body and includes
the following officers:
- Director-General
- Deputy Director-General
- Standing Members
- Executive Secretary
The Executive Board has the following responsibilities:
- Determines
the working plan and program of the Organization.
- Determines other main affairs of the
Organization.
4. The organization may have expert groups (committees).
The expert groups are composed of a number of domestic
senior consultants who have been involved to certain
extent in the decision-making process of the public
health policy. The expert group has the special task
to guide the Organization’s activities with a macro perspective
to better suit China’s current condition.
Part V Duties & Term of Officers
1. Duties of the Director-General:
- The Director-General is the authorized
representative of the organization, who represents
the organization outwards in China as well as abroad.
The Director-General is entitled to sign all written
documents on and in behalf of the organization.
- Conducts and presides over all meeting
of the Organization.
- Appoints an individual to any office that
becomes vacant subject to the Organization’s
Executive Board approval.
- Submits an annual report of activities
and financial transaction to members of the Organization.
- Submits an annual report to ISPOR
2. Duties of the Deputy Director-General:
- The deputy Director-General represents
the Director-General in absence of the latter.
- Conducts and presides over all meetings
of Organization in the absence of the Director-General.
- Assists the Director-General with the
responsibilities of Organization.
3. Duties of the Standing Members:
- Approve working plan and program of the
Organization
- Determines and approves other main affairs
of the Organization.
- Perform duties as assigned by the the
Executive Board
4. Duties of the Executive Secretary:
The Executive Secretary shall be hired by the Executive
Board and will perform the following duties.
- Maintain all records of the Organization.
- Collect member dues and maintain accurate
records of all sources of income.
- Employ and manage staff as necessary
to perform the duties of the Organization.
- Plan and organize meetings.
- Communicate with members, Executive Board
,and experts.
5. Director-General, Deputy Director-General, Standing
Members and Executive Secretary shall be elected
every four years by the Membership Conference; the
Director-General shall hold the office for no more
than two consecutive terms, and other officers may
continue to serve upon reelection. If 2/3 of the
members present at the Membership Conference vote
to remove the Director-General, then she or he shall
leave office immediately.
Part VI Conferences
1. The Organization holds meeting as needed to fulfill
its mission.
Part VII Resources and expenses of the organization
funds
1. Resources of the funds include:
- membership fees: Individual membership
fee is 120RMB per year; while organizational membership
fee is 1200RMB per year. Student member only pays
half of the individual membership fee.
- sponsoring fees
- funds raised by the pharmaceutical industry
- interests
- other earnings
2. The funds are used in:
- ordinary expenses
- promotion of the organization
- establishment and maintenance of the
pharmacoeconomic database
- meetings, lectures
and other activities
|
